-
Detailed Analysis Generate Full Report Add to Watchlist
Values as of: 2025-05-05
3020-OL:HK:HK-X DBMSCIUSA (HKD)
COMMON STOCK | Other |
Last Closing
USD 1292.5Change
0.00 (0.00)%Market Cap
N/AVolume
15.00Analyst Target
N/A
N/A
Verdict
Values as of: 2025-05-05
COMMON STOCK | Other |
Last Closing
USD 1292.5Change
0.00 (0.00)%Market Cap
N/AVolume
15.00Analyst Target
N/AN/A
Verdict
There is no Profile data available for 3020-OL.HK.
Currency: HKD
Country : Hong Kong
Symbol | Name | Price(Change) | Market Cap |
---|---|---|---|
1863:HK | China Longevity Group Company .. |
N/A |
USD 1.17B |
8355:HK | I-CONTROL |
N/A |
USD 0.39B |
8343:HK | HongGuang Lighting Holdings Co.. |
N/A |
USD 0.31B |
0648:HK | CHINA RENJ |
N/A |
USD 0.12B |
0177-OL:HK | JIANGSU EXPRESS |
N/A |
N/A |
0243-OL:HK | QPL INT'L |
N/A |
N/A |
0259-OL:HK | YEEBO (INT'L H) |
N/A |
N/A |
0187-OL:HK | JINGCHENG MAC |
N/A |
N/A |
0182-OL:HK | CHINA WINDPOWER |
N/A |
N/A |
0239-OL:HK | PAK FAH YEOW |
N/A |
N/A |
Symbol | Name | Weight | Mer | Price(Change) | Market Cap |
---|---|---|---|---|---|
IHF | iShares U.S. Healthcare P.. | 11.37 % | 0.43 % |
+0.17 (+-0.49%) |
N/A |
DXZ:CA | Dynamic Active U.S. Mid-C.. | 11.35 % | 0.87 % |
+0.07 (+-0.49%) |
CAD 0.04B |
TETF | 6.19 % | 0.64 % |
N/A |
N/A | |
BOUT | Innovator ETFs Trust - In.. | 5.99 % | 0.80 % |
-0.03 (-0.49%) |
USD 0.01B |
FHI:CA | CI Health Care Giants Cov.. | 5.16 % | 0.75 % |
-0.01 (-0.49%) |
CAD 0.10B |
FHI-B:CA | CI Health Care Giants Cov.. | 5.16 % | 0.00 % |
N/A |
CAD 0.05B |
IAI | iShares U.S. Broker-Deale.. | 4.32 % | 0.42 % |
-0.61 (-0.49%) |
N/A |
MID | American Century Mid Cap .. | 4.22 % | 0.00 % |
-0.10 (-0.49%) |
USD 0.07B |
LCG | Sterling Capital Focus Eq.. | 4.17 % | 0.00 % |
-0.06 (-0.49%) |
USD 0.03B |
LONG:CA | CI Global Longevity Econo.. | 4.01 % | 0.00 % |
+0.47 (+-0.49%) |
CAD 3.64M |
CBUF:XETRA | iShares MSCI World Health.. | 3.38 % | 0.00 % |
+0.04 (+-0.49%) |
N/A |
VSMV | VictoryShares US Multi-Fa.. | 3.37 % | 0.35 % |
-0.22 (-0.49%) |
USD 0.11B |
HDIV | 2.83 % | 0.00 % |
N/A |
N/A | |
TDOC:CA | TD Global Healthcare Lead.. | 2.25 % | 0.00 % |
-0.09 (-0.49%) |
CAD 0.08B |
XHS | SPDR® S&P Health Care Se.. | 2.17 % | 0.35 % |
-0.16 (-0.49%) |
USD 0.09B |
FLXG:LSE | Franklin LibertyQ Global .. | 1.87 % | 0.00 % |
N/A |
N/A |
FRGE:LSE | Franklin LibertyQ Global .. | 1.87 % | 0.00 % |
N/A |
USD 0.02B |
KCE | SPDR® S&P Capital Market.. | 1.80 % | 0.35 % |
-0.48 (-0.49%) |
N/A |
DSTL | Distillate US Fundamental.. | 1.76 % | 0.00 % |
-0.21 (-0.49%) |
USD 1.79B |
RYH | 1.72 % | 0.40 % |
N/A |
N/A | |
HONR | 1.20 % | 0.65 % |
N/A |
N/A | |
CVY | Invesco Zacks Multi-Asset.. | 1.13 % | 0.65 % |
-0.17 (-0.49%) |
USD 0.10B |
SMD | 0.45 % | 0.10 % |
N/A |
N/A | |
ESGL | ESGL Holdings Limited Ord.. | 0.00 % | 0.40 % |
-0.04 (-0.49%) |
USD 0.08B |
FXH | First Trust Health Care A.. | 0.00 % | 0.63 % |
-0.56 (-0.49%) |
USD 0.89B |
JKH | iShares Morningstar Mid-C.. | 0.00 % | 0.30 % |
N/A |
N/A |
RYF | 0.00 % | 0.40 % |
N/A |
N/A | |
VVL:CA | Vanguard Global Value Fac.. | 0.00 % | 0.40 % |
-0.03 (-0.49%) |
N/A |
WBIF | WBI BullBear Value 3000 E.. | 0.00 % | 1.05 % |
-0.14 (-0.49%) |
N/A |
XXM:CA | 0.00 % | 0.68 % |
N/A |
N/A | |
FSWD:LSE | iShares Edge MSCI World M.. | 0.00 % | 0.00 % |
N/A |
N/A |
IFSW:LSE | iShares Edge MSCI World M.. | 0.00 % | 0.00 % |
N/A |
N/A |
IBCZ:F | iShares IV Public Limited.. | 0.00 % | 0.00 % |
+0.02 (+-0.49%) |
N/A |
IS07:F | iShares IV Public Limited.. | 0.00 % | 0.00 % |
+0.01 (+-0.49%) |
N/A |
IS07:XETRA | iShares Edge MSCI World M.. | 0.00 % | 0.00 % |
-0.01 (-0.49%) |
N/A |
CBLS | Elevation Series Trust | 0.00 % | 0.00 % |
-0.01 (-0.49%) |
USD 0.04B |
CBSE | Elevation Series Trust | 0.00 % | 0.00 % |
-0.23 (-0.49%) |
USD 0.02B |
IMCG | iShares Morningstar Mid-C.. | 0.00 % | 0.00 % |
-0.02 (-0.49%) |
N/A |
Market Performance vs. Industry/Classification (Other) | Market Performance vs. Exchange | ||||||
Value | Sector Median | Percentile Rank | Grade | Market Median | Percentile Rank | Grade | |
YTD | |||||||
Capital Gain | -4.89% | 44% | F | 43% | F | ||
Dividend Return | N/A | N/A | N/A | N/A | N/A | ||
Total Return | -4.89% | 44% | F | 43% | F | ||
Trailing 12 Months | |||||||
Capital Gain | 9.91% | 63% | D | 65% | D | ||
Dividend Return | N/A | N/A | N/A | N/A | N/A | ||
Total Return | 9.91% | 60% | D- | 62% | D | ||
Trailing 5 Years | |||||||
Capital Gain | 109.65% | 85% | B | 89% | A- | ||
Dividend Return | N/A | N/A | N/A | N/A | N/A | ||
Total Return | 109.65% | 85% | B | 87% | B+ | ||
Average Annual (5 Year Horizon) | |||||||
Capital Gain | 15.32% | 77% | C+ | 75% | C | ||
Dividend Return | 15.32% | 75% | C | 73% | C | ||
Total Return | N/A | N/A | N/A | N/A | N/A | ||
Risk Return Profile | |||||||
Volatility (Standard Deviation) | 18.38% | 80% | B- | 80% | B- | ||
Risk Adjusted Return | 83.38% | 96% | N/A | 97% | N/A | ||
Market Capitalization | N/A | N/A | N/A | N/A | N/A |
Target Price Action | Rating Action | Analyst | Rating | Price | Date |
---|
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.
The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.
There is nothing we particularly dislike